__timestamp | Dr. Reddy's Laboratories Limited | Eli Lilly and Company |
---|---|---|
Wednesday, January 1, 2014 | 12402000000 | 4733600000 |
Thursday, January 1, 2015 | 17449000000 | 4796400000 |
Friday, January 1, 2016 | 17834000000 | 5243900000 |
Sunday, January 1, 2017 | 19551000000 | 5281800000 |
Monday, January 1, 2018 | 18265000000 | 5051200000 |
Tuesday, January 1, 2019 | 15607000000 | 5595000000 |
Wednesday, January 1, 2020 | 15410000000 | 6085700000 |
Friday, January 1, 2021 | 16541000000 | 7025900000 |
Saturday, January 1, 2022 | 17482000000 | 7190800000 |
Sunday, January 1, 2023 | 19381000000 | 9313400000 |
Monday, January 1, 2024 | 22873000000 | 14271000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Eli Lilly and Company and Dr. Reddy's Laboratories Limited have been at the forefront of this race. From 2014 to 2023, Dr. Reddy's consistently outspent Eli Lilly, with R&D expenses peaking at an impressive 22.9 billion in 2024. In contrast, Eli Lilly's R&D spending showed a steady increase, reaching 9.3 billion in 2023, marking a 97% growth from 2014. This trend highlights Dr. Reddy's aggressive investment strategy, while Eli Lilly's gradual increase reflects a more measured approach. The data for 2024 is incomplete for Eli Lilly, suggesting a potential shift in strategy or reporting. As these companies continue to innovate, their R&D investments will be crucial in shaping the future of healthcare.
Analyzing R&D Budgets: Eli Lilly and Company vs Zoetis Inc.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and BeiGene, Ltd.
R&D Insights: How Eli Lilly and Company and Verona Pharma plc Allocate Funds
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and MiMedx Group, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending